New hope for advanced cancer patients in early drug trial
NCT ID NCT07213817
Summary
This early-stage study is testing a new drug called IPN60300 in adults with advanced solid tumors that have spread or cannot be removed by surgery. The main goals are to find a safe and effective dose and to see if the drug can shrink tumors. All participants will receive the drug by injection, and researchers will closely monitor how their bodies handle it and how their cancer responds.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre Leon Berard
NOT_YET_RECRUITINGLyon, France
-
Gustave Roussy Cancer Campus Grand Paris- (Institut de Cancerologie Gustave-Roussy)
NOT_YET_RECRUITINGVillejuif, France
-
Hospital Universitari Vall d'Hebron
NOT_YET_RECRUITINGBarcelona, Spain
-
Institut de Cancerologie de l'Ouest (ICO)- CRLCC Rene Gauducheau
NOT_YET_RECRUITINGSaint-Herblain, France
-
MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
-
NEXT Oncology
RECRUITINGSan Antonio, Texas, 78229, United States
-
NEXT Oncology
RECRUITINGFairfax, Virginia, 22031, United States
-
NEXT Quiron-Barcelona
NOT_YET_RECRUITINGBarcelona, Spain
-
START Madrid CIOCC Hospital Universitario HM Sanchinarro
NOT_YET_RECRUITINGMadrid, Spain
-
START Midwest
RECRUITINGGrand Rapids, Michigan, 49546, United States
-
Sidney Kimmel Cancer Center
NOT_YET_RECRUITINGPhiladelphia, Pennsylvania, 19107, United States
-
Yale Cancer Center-Yale University
NOT_YET_RECRUITINGNew Haven, Connecticut, 06510, United States
Conditions
Explore the condition pages connected to this study.